Researchers find higher doses of hydroxychloroquine, azithromycin increase COVID patient survival by 200 percent
Researchers in New Jersey discover treating patients with higher levels of hydroxychloroquine increases COVID patient survival by up to 200 percent. One America’s Pearson Sharp has more.